|
|
| Rapport d’activité 2001 | |
April 2002
- PART 1 - PROPRIETARY MEDICINES
- Chapter I – THE REIMBURSABLE PROPRIETARY MEDICINES MARKET
- Chapter II – REGULATION ADOPTED BY AGREEMENT
- Chapter III - NEGOtIATION OF THE drug PRICE
PART TWO – MEDICAL DEVICES- Chapter I – REIMBURSED COSTS AND THEIR TREND
- Chapter II – INTRODUCTION OF THE REFORM
- Chapter III - THE OPINIONS OF THE COMMITTEE
ANNEXES Annex 1. Ministers' guideline letter Annex 2. The members of the economic committee for health products Annex 3. rapporteurs TO THE COMMITTEE Annex 4. Table of thresholds triggering discounts by pharmacotherapeutic class Annex 5. DRUG PRICE NEGOTIATION METHODS Annex 6. Standard clauses Annex 7. The committee’s organisation chart Annex 8. details of committee members Annex 9. Declarations of interests
Economic Committee
for Health ProductsAnnual Report 2001
In accordance with article D. 162-2-4 of the Social Security Code, each year, the Economic Committee for Health Products hands a report on its activities in to the ministers responsible for social security, health, the economy and industry. The newly introduced article L. 162-17-3 of the Social Security Code also makes provision for the submission of this report to Parliament.
This report outlines the main activities of the Committee in 2001, a year marked by the extension of its remit to health products other than proprietary medicines(1).
- Part one deals with proprietary medicines.
Chapter one is devoted to the proprietary medicines market in 2001.
Chapter two deals with the regulation of the proprietary medicines market in 2001 and actions taken to that end by the Committee in application of the Social Security Code and ministerial guidelines.
Chapter three relates to pricing. Firstly it presents a statistical overview of the Committee’s activities on this matter (type of applications, processing periods). It also describes the methods implemented by the Committee in 2001 for price negotiations and gives an indication of pricing levels.
- Part two concerns health products other than proprietary medicines.
Chapter one is devoted to the description and trends in the medical devices market.
Chapter two deals with the reform in the reimbursement of the cost of medical devices and the action taken by the Committee for the implementation of this reform.
Chapter three is devoted to special opinions of the Committee.
1 The Social Security Financing Act for 2000 extended the remit of the Committee to reimbursable health products other than proprietary medicines; the decrees for implementation dated 26 March 2001 were published in the Journal Officiel of 28 March 2001.
 |
|